[go: up one dir, main page]

EP0596905A1 - Vascular prosthesis - Google Patents

Vascular prosthesis

Info

Publication number
EP0596905A1
EP0596905A1 EP92914375A EP92914375A EP0596905A1 EP 0596905 A1 EP0596905 A1 EP 0596905A1 EP 92914375 A EP92914375 A EP 92914375A EP 92914375 A EP92914375 A EP 92914375A EP 0596905 A1 EP0596905 A1 EP 0596905A1
Authority
EP
European Patent Office
Prior art keywords
prosthesis
section
mandrel
vascular prosthesis
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP92914375A
Other languages
German (de)
French (fr)
Inventor
Christopher John 22 Keswick Avenue Underwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polymedica Industries Inc
Original Assignee
Polymedica Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymedica Industries Inc filed Critical Polymedica Industries Inc
Publication of EP0596905A1 publication Critical patent/EP0596905A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/09—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
    • B29C48/10—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels flexible, e.g. blown foils
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/12—Articles with an irregular circumference when viewed in cross-section, e.g. window profiles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/88—Thermal treatment of the stream of extruded material, e.g. cooling
    • B29C48/919—Thermal treatment of the stream of extruded material, e.g. cooling using a bath, e.g. extruding into an open bath to coagulate or cool the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001—Designing or manufacturing processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/09—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B29L2031/7532—Artificial members, protheses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B29L2031/7532—Artificial members, protheses
    • B29L2031/7534—Cardiovascular protheses

Definitions

  • This invention concerns a vascular prosthesis adapted for use as an access graft, for example, for use in dialysis patients.
  • the present invention provides a vascular prosthesis for use as an- access graft which overcomes., to some extent, the problems aforesaid. According to the invention there is provided a vascular prosthesis adapted for use as an access graft which has a permanent set, kink-resistant U-bend section.
  • the cross-section of the prosthesis may be circular or it may be non-circular.
  • Examples of non- circular cross-sections for prostheses are tricuspid epitrochoid and deltoid.
  • the vascular prosthesis may be arranged to be 'self sealing' after multiple needle puncture.
  • a method of making a vascular prosthesis which comprises the steps: a) making a length of bio-compatible vascular prosthesis by coagulation casting and not allowing the casting to dry, b) forming a U-bend in the prosthesis without introducing a kink therein, c) drying the prosthesis while so formed.
  • a method of making a vascular prosthesis which comprises the steps: a) making a length of bio-compatible vascular prosthesis by coagulation casting and allowing the casting to dry, then re-wetting the casting. b) forming a U-bend in the prosthesis without introducing a kink therein, c) drying the prosthesis while so formed.
  • the prosthesis may be made of a heat degradable polymer and then drying is effected at a temperature which will not degrade the polymer. However, drying may clearly be carried out at temperatures up to 40°C (blood heat) as polymers which will degrade at such temperatures are obviously unsuitable for implantation.
  • a solution of coagulatable polymer may be dissolved in an organic solvent and may be coagulation cast onto a mandrel to make the prosthesis.
  • the mandrel may have a circular cross-section, or a non-circular cross-section.
  • non- circular cross-sections are tricuspid epitrochoid and deltoid.
  • the mandrel may be a pre-formed tube of PTFE.
  • the mandrel may be dip coated in the polymer solution.
  • the polymer solution may, however, be extruded through an extrusion head onto the mandrel to more easily provide a prosthesis of uniform wall thickness.
  • the polymer solution may contain a pore-forming agent soluble in a coagulant to leave a porous cast.
  • the polymer may comprise polyurethane, and may be a linear segmented poly(ether)urethane with a number average molecular weight in the region 20,000 to 60,000.
  • the solvent may be aprotic, and may comprise N,N-Dimethylacetamide or N,N-Dimethylformamide.
  • the concentration of the polymer in the solution may be between 10 and 30 grams/decilitre.
  • the coagulant may comprise water.
  • Figure 1 shows a. top view of the prosthesis of the invention
  • Figure 2 shows the cross-section of three types of the prosthesis shown in Figure 1;
  • Figure 3 shows the cross-section of three types of mandrels to produce the prosthese ' s of Figure 2.
  • Figure 1 shows a vascular prosthesis 20 adapted for use as an access graft having a permanent set, kink-resistant U-bend section 21.
  • the cross-sectional shape of the prosthesis 20 is not limited.
  • Figure 2 shows three cross-sections of the prosthesis 20, a circular cross-section (a); a tricuspid epitrochoid cross-section (b) and a deltoid cross-section (c). It may be arranged for the prosthesis 20 to have a non-circular cross-section, whereof the lumen 22 will not totally occlude, thus further increasing the kink-resistance of prosthesis 20,
  • the prosthesis 20 is made from a bio-compatible material, such as an elastomer, or a combination of elastomer and polytetrafluoroethylene (PTFE).
  • a bio-compatible material such as an elastomer, or a combination of elastomer and polytetrafluoroethylene (PTFE).
  • Preferred elastomers include polyurethane, polyurethaneurea, segmented polyurethanes and segmented polyurethaneureas. These materials give the prosthesis 20 the property of tending to be 'self-sealing' after needle_puncture, even after multiple needle puncture.
  • the prosthesis 20 has a wall thickness and lumen size capable of withstanding multiple needle puncture by a large bore, i.e., 15 gauge needle used for dialysis treatment, while maintaining a compliance similar to that of natural vessels, overcoming the problem which at present prevents such thicker walled, small diameter conventional prostheses being used as access grafts.
  • the prosthesis 20, having a permanent set, kink-resistant U-bend 21 is made from a length of vascular prosthesis by coagulation casting a solution of coagulatable heat degradable polymer dissolved in an organic solvent onto a mandrel. Before allowing the casting to dry, or after re-wetting the casting after drying, a U-bend is formed in the prosthesis without introducing any kink therein, and the prosthesis so formed is dried.
  • the prosthesis 20 is dried in an oven at a temperature which will not degrade the polymer, usually up to 40°C
  • the U-bend 21 is formed in the length of prosthesis, after the introduction of an internal flexible former to prevent collapse of the lumen of the prosthesis on bending, either by drying over a shaped former, or by simply bending the length of prosthesis, having locating means to maintain the U-bend in position until dried. Once dried the internal flexible former is removed.
  • a solution of coagulatable polymer such as a linear segmented polyetherurethane with a number average weight of 20,000 to 60,000, is dissolved in a solution comprising an organic solvent, such as N,N-Dimethyl- acetamide or N,N-Dimethylformamide, at a concentration of polymer in the solution of between 10 and 30 grams/ decilitre.
  • an organic solvent such as N,N-Dimethyl- acetamide or N,N-Dimethylformamide
  • the polymer solution contains a pore-forming agent, soluble in a coagulant to leave a porous cast, such as sodium hydrogen carbonate ground to an average particle size of 60 microns in an amount between 10 and 60 percent by weight.
  • a pore-forming agent such as sodium hydrogen carbonate ground to an average particle size of 60 microns in an amount between 10 and 60 percent by weight.
  • the polymer solution also contains a surfactant, such as sodium dodecyl sulphate, in an amount between 1 and 10 percent by weight.
  • a surfactant such as sodium dodecyl sulphate
  • a length of prosthesis- is produced either by dip coating a mandrel in the polymer solution, or, to more easily produce a prosthesis having a uniform wall thickness, by extruding the polymer solution through an extrusion head as described in GB-A-2,204,873.
  • the polymer-coated mandrel is then immersed iri a coagulant and allowed to coagulate.
  • the preferred coagulant is water which is maintained at a constant temperature throughout the coagulation process, usually 40°C.
  • the coagulation process normally takes 1 to 2 hours.
  • Mandrel is not limited in its cross-section.
  • Figure 3 shows three examples of mandrels.
  • Mandrel 23 has a circular cross-section and is used to produce the prosthesis of Figure 2(a).
  • Mandrel 24 has a tricuspid epitrochoid cross-section and is used to produce the prosthesis of Figure 2(b).
  • Mandrel 25 has a deltoid cross-section and is used to produce the prosthesis of Figure 2(c) .

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Prostheses (AREA)

Abstract

Prothèse vasculaire (20) adaptée pour servir de court-circuit artério-veineux possédant une section coudée en U (21) indéformable et résistante à l'entortillement.Vascular prosthesis (20) adapted to serve as an arteriovenous short-circuit having a bent U-shaped section (21) which is undeformable and resistant to kinking.

Description

VASCULAR PROSTHESIS
This invention concerns a vascular prosthesis adapted for use as an access graft, for example, for use in dialysis patients.
At present, to make a vascular access graft, straight pieces of conventional artificial vascular prostheses, having circular cross-sections, are placed, usually, in the forearm of patients during surgery, and simply bent into a loop in situ. However, a major problem is that the artificial vessel may kink at the point where the vessel bends, and, because the vessel is circular, the lumen will totally occlude thus interrupt¬ ing normal blood flow. This problem may be overcome to some extent by having access grafts with thick walls and small internal diameters which are more kink resistant than those with thinner walls and larger internal diameters. However if the walls of the graft are too thick and lumen too small, the graft will not only have a reduced compliance but also it will be very difficult to repeatedly introduce the large bore needle, i.e. 15 gauge, used for dialysis purposes.
The present invention provides a vascular prosthesis for use as an- access graft which overcomes., to some extent, the problems aforesaid. According to the invention there is provided a vascular prosthesis adapted for use as an access graft which has a permanent set, kink-resistant U-bend section.
The cross-section of the prosthesis may be circular or it may be non-circular. Examples of non- circular cross-sections for prostheses are tricuspid epitrochoid and deltoid.
The vascular prosthesis may be arranged to be 'self sealing' after multiple needle puncture.
According to the invention there is also provided a method of making a vascular prosthesis which comprises the steps: a) making a length of bio-compatible vascular prosthesis by coagulation casting and not allowing the casting to dry, b) forming a U-bend in the prosthesis without introducing a kink therein, c) drying the prosthesis while so formed.
According to the invention there is also provided a method of making a vascular prosthesis which comprises the steps: a) making a length of bio-compatible vascular prosthesis by coagulation casting and allowing the casting to dry, then re-wetting the casting. b) forming a U-bend in the prosthesis without introducing a kink therein, c) drying the prosthesis while so formed.
The prosthesis may be made of a heat degradable polymer and then drying is effected at a temperature which will not degrade the polymer. However, drying may clearly be carried out at temperatures up to 40°C (blood heat) as polymers which will degrade at such temperatures are obviously unsuitable for implantation.
A solution of coagulatable polymer may be dissolved in an organic solvent and may be coagulation cast onto a mandrel to make the prosthesis.
The mandrel may have a circular cross-section, or a non-circular cross-section. Examples of non- circular cross-sections are tricuspid epitrochoid and deltoid.
The mandrel may be a pre-formed tube of PTFE.
The mandrel may be dip coated in the polymer solution.
The polymer solution may, however, be extruded through an extrusion head onto the mandrel to more easily provide a prosthesis of uniform wall thickness. The polymer solution may contain a pore-forming agent soluble in a coagulant to leave a porous cast.
The polymer may comprise polyurethane, and may be a linear segmented poly(ether)urethane with a number average molecular weight in the region 20,000 to 60,000.
The solvent may be aprotic, and may comprise N,N-Dimethylacetamide or N,N-Dimethylformamide.
The concentration of the polymer in the solution may be between 10 and 30 grams/decilitre.
The coagulant may comprise water.
The invention will be further apparent from the following description with reference to the figures of the accompanying drawings, which show by way of example only, three forms of the vascular prosthesis embodying same.
Of the drawings :-
Figure 1 shows a. top view of the prosthesis of the invention; Figure 2 shows the cross-section of three types of the prosthesis shown in Figure 1;
Figure 3 shows the cross-section of three types of mandrels to produce the prosthese's of Figure 2.
Figure 1 shows a vascular prosthesis 20 adapted for use as an access graft having a permanent set, kink-resistant U-bend section 21.
The cross-sectional shape of the prosthesis 20 is not limited. Figure 2 shows three cross-sections of the prosthesis 20, a circular cross-section (a); a tricuspid epitrochoid cross-section (b) and a deltoid cross-section (c). It may be arranged for the prosthesis 20 to have a non-circular cross-section, whereof the lumen 22 will not totally occlude, thus further increasing the kink-resistance of prosthesis 20,
The prosthesis 20, is made from a bio-compatible material, such as an elastomer, or a combination of elastomer and polytetrafluoroethylene (PTFE). Preferred elastomers include polyurethane, polyurethaneurea, segmented polyurethanes and segmented polyurethaneureas. These materials give the prosthesis 20 the property of tending to be 'self-sealing' after needle_puncture, even after multiple needle puncture.
The prosthesis 20 has a wall thickness and lumen size capable of withstanding multiple needle puncture by a large bore, i.e., 15 gauge needle used for dialysis treatment, while maintaining a compliance similar to that of natural vessels, overcoming the problem which at present prevents such thicker walled, small diameter conventional prostheses being used as access grafts.
The prosthesis 20, having a permanent set, kink-resistant U-bend 21 is made from a length of vascular prosthesis by coagulation casting a solution of coagulatable heat degradable polymer dissolved in an organic solvent onto a mandrel. Before allowing the casting to dry, or after re-wetting the casting after drying, a U-bend is formed in the prosthesis without introducing any kink therein, and the prosthesis so formed is dried.
The prosthesis 20 is dried in an oven at a temperature which will not degrade the polymer, usually up to 40°C
The U-bend 21 is formed in the length of prosthesis, after the introduction of an internal flexible former to prevent collapse of the lumen of the prosthesis on bending, either by drying over a shaped former, or by simply bending the length of prosthesis, having locating means to maintain the U-bend in position until dried. Once dried the internal flexible former is removed.
A solution of coagulatable polymer, such as a linear segmented polyetherurethane with a number average weight of 20,000 to 60,000, is dissolved in a solution comprising an organic solvent, such as N,N-Dimethyl- acetamide or N,N-Dimethylformamide, at a concentration of polymer in the solution of between 10 and 30 grams/ decilitre.
In addition, the polymer solution contains a pore-forming agent, soluble in a coagulant to leave a porous cast, such as sodium hydrogen carbonate ground to an average particle size of 60 microns in an amount between 10 and 60 percent by weight.
The polymer solution also contains a surfactant, such as sodium dodecyl sulphate, in an amount between 1 and 10 percent by weight.
A length of prosthesis- is produced either by dip coating a mandrel in the polymer solution, or, to more easily produce a prosthesis having a uniform wall thickness, by extruding the polymer solution through an extrusion head as described in GB-A-2,204,873. The polymer-coated mandrel is then immersed iri a coagulant and allowed to coagulate.
The preferred coagulant is water which is maintained at a constant temperature throughout the coagulation process, usually 40°C. The coagulation process normally takes 1 to 2 hours.
The mandrel is not limited in its cross-section. Figure 3 shows three examples of mandrels. Mandrel 23 has a circular cross-section and is used to produce the prosthesis of Figure 2(a). Mandrel 24 has a tricuspid epitrochoid cross-section and is used to produce the prosthesis of Figure 2(b). Mandrel 25 has a deltoid cross-section and is used to produce the prosthesis of Figure 2(c) .
It will be appreciated that it is not intended to limit the invention to the above example only, many variations, such as might readily occur to one skilled in the art, being possible, without departing from the scope thereof as defined by the appended claims.

Claims

1. A vascular prosthesis adapted for use as access graft having a permanent set, kink-resistant U-bend section.
2. A vascular prosthesis according to claim 1, wherein the cross-section of the prosthesis is circular.
3. A vascular prosthesis according to claim 1, wherein the cross-section of the prosthesis is non-circular.
4. A vascular prosthesis according to claim 2, wherein the cross-section is tricuspid epitrochoid.
5. A vascular prosthesis according to claim 3, wherein the cross-section is deltoid.
6. A vascular prosthesis according to any preceding claim, comprising a bio-compatible material.
7. A vascular prosthesis according to any preceding claim wherein the prosthesis is self sealing after multiple needle puncture.
8. A method of making a vascular prosthesis having a permanent set, kink-resistant U-bend section, comprising the steps: a) making a length of bio-compatible-vascular prosthesis by coagulation casting and not allowing the casting to dry, b) forming a U-bend in the prosthesis without introducing a kink therein, c) drying the prosthesis while so formed.
9. A method of making a vascular prosthesis which comprises the steps: a) making a length of bio-compatible vascular prosthesis by coagulation casting and allowing the casting to dry, then re-wetting the casting, b) forming a U-bend in the prosthesis without introducing a kink therein, c) drying the prosthesis while so formed.
10. A method according to any one of claims 9 or 10, wherein the prosthesis is dried at a temperature which will not degrade the bio-compatible material.
11. A method according to claim 8,' wherein the drying temperature is less than 40°C
12. A method according to any one of claims 8 to 11, wherein a solution of coagulatable polymer dissolved in a solution comprising an organic solvent is coagulation cast onto a mandrel.
13. A method according to claim 12, wherein the mandrel has a circular cross-section
14. A method according to claim 12, wherein the mandrel has a non-circular cross-section.
15. A method according to claim 14, wherein the mandrel has a tricuspid epitrochoid cross-section.
16. A method according to claim 14, wherein the mandrel has a deltoid cross section.
17. A method according to any one of claims 12 to
16, wherein the mandrel is a pre-formed tube of PTFE.
18. A method according to any one of claims 8 to
17, wherein the mandrel is dip coated in the polymer solution to provide a prosthesis of uniform wall thickness.
19. A method according to any one of claims 8 to 18, wherein the polymer solution is extruded through an extrusion head onto a mandrel to provide a prosthesis of uniform wall thickness.
20. A method according to any one of claims 8 to 19, wherein the polymer solution contains a pore-forming agent soluble in a coagulant to leave a porous cast.
21. A method according to any one of claims 8 to 20, wherein the polymer comprises polyurethane.
22. A method according to claim 21, wherein the polyurethane is a linear segmented poly(ether)urethane with a number average molecular weight in the region 20,000 to 60,000.
23. A method according to any one claims 8 to 22, wherein the solvent is aprotic.
24. A method according to claim 23, wherein the solvent comprises N,N-Dimethylacetamide or N,N-Dimethyl- formamide.
25. A method according to any one of claims 8 to 24, wherein the concentration of the polymer in the solution is between 10 and 30 grams/decilitre.
26. A method according to any one of claims 8 to 25, wherein the coagulant comprises water.
EP92914375A 1991-08-01 1992-07-21 Vascular prosthesis Ceased EP0596905A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919116563A GB9116563D0 (en) 1991-08-01 1991-08-01 Vascular prosthesis ii
GB9116563 1991-08-01
PCT/GB1992/001338 WO1993002637A1 (en) 1991-08-01 1992-07-21 Vascular prosthesis

Publications (1)

Publication Number Publication Date
EP0596905A1 true EP0596905A1 (en) 1994-05-18

Family

ID=10699303

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92914375A Ceased EP0596905A1 (en) 1991-08-01 1992-07-21 Vascular prosthesis

Country Status (4)

Country Link
EP (1) EP0596905A1 (en)
AU (1) AU2329892A (en)
GB (1) GB9116563D0 (en)
WO (1) WO1993002637A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7621794A (en) * 1993-10-01 1995-05-01 Imperial College Of Science, Technology And Medicine Vascular prostheses
GB2297263B (en) * 1993-10-01 1998-04-01 Imperial College Vascular prostheses
GB9610273D0 (en) * 1996-05-16 1996-07-24 Cardiotech International Limit Making an access graft

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2248015A1 (en) * 1973-10-17 1975-05-16 Rhone Poulenc Ind Artificial ureter or urethra - watertight flexible tube has helical rib in outside wall to prevent creasing
US3882862A (en) * 1974-01-11 1975-05-13 Olga Berend Arteriovenous shunt
US4546499A (en) * 1982-12-13 1985-10-15 Possis Medical, Inc. Method of supplying blood to blood receiving vessels
FI875125A7 (en) * 1986-03-27 1987-11-19 Advanced Vascular Tech Inc Vascular prosthesis and device and method for manufacturing the same.
EP0269449A3 (en) * 1986-11-26 1988-12-21 BAXTER INTERNATIONAL INC. (a Delaware corporation) Porous flexible radially expanded fluoropolymers and process for producing the same
GB8708476D0 (en) * 1987-04-09 1987-05-13 Charlesworth D Making polymer material
US4938766A (en) * 1987-08-28 1990-07-03 Jarvik Robert K Prosthetic compliance devices
EP0334567A3 (en) * 1988-03-21 1990-04-25 Ethicon, Inc. Improvements in synthetic vascular grafts
GB8827222D0 (en) * 1988-11-22 1988-12-29 Newtec V P Ltd Composite structure
US4969896A (en) * 1989-02-01 1990-11-13 Interpore International Vascular graft prosthesis and method of making the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9302637A1 *

Also Published As

Publication number Publication date
AU2329892A (en) 1993-03-02
WO1993002637A1 (en) 1993-02-18
GB9116563D0 (en) 1991-09-18

Similar Documents

Publication Publication Date Title
EP0130401B1 (en) Artificial vessel and process for preparing the same
US7727274B2 (en) Porous synthetic vascular grafts with oriented ingrowth channels
CA2685454C (en) Eptfe crimped graft
US7632306B2 (en) Foam-type vascular prosthesis with well-defined angio-permissive open porosity
EP0128501B1 (en) Artificial vessel and process for preparing the same
EP0157178B1 (en) Artificial vessel and process for preparing the same
US3337673A (en) Uniformly corrugated prosthesis and process of making same
US5756035A (en) Method of making an access graft and a vascular prosthesis
EP0596905A1 (en) Vascular prosthesis
US5462704A (en) Method for preparing a porous polyurethane vascular graft prosthesis
WO1993002636A1 (en) Vascular prosthesis
JPH0254101B2 (en)
WO1992002195A1 (en) Artificial blood vessel and production thereof
JPH0261260B2 (en)
JP2553522B2 (en) Medical tube and method of manufacturing the same
JPS6244260A (en) Artificial blood vessel excellent in openability
JPH0237184B2 (en)
EP1669044A2 (en) Foam-type vascular prosthesis with well-defined angio-permissive open porosity
JPS63222758A (en) medical tube
JPS625354A (en) Artificial blood vessel
JPH01158966A (en) Manufacturing method for medical tubes
JPS61293451A (en) Artificial blood vessel
JPS60242857A (en) Artificial blood vessel

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940222

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB

17Q First examination report despatched

Effective date: 19950613

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19960906